Inmode Ltd   (INMD)
Other Ticker:  
Price: $21.4400 $0.09 0.422%
Day's High: $21.65 Week Perf: 2.24 %
Day's Low: $ 21.20 30 Day Perf: -7.98 %
Volume (M): 1,078 52 Wk High: $ 48.25
Volume (M$): $ 23,119 52 Wk Avg: $30.73
Open: $21.34 52 Wk Low: $18.57

 Market Capitalization (Millions $) 1,843
 Shares Outstanding (Millions) 86
 Employees 563
 Revenues (TTM) (Millions $) 492
 Net Income (TTM) (Millions $) 198
 Cash Flow (TTM) (Millions $) 47
 Capital Exp. (TTM) (Millions $) 1

Inmode Ltd
Inmode Ltd is a global technology company that specializes in developing, manufacturing, and marketing innovative medical devices for the aesthetic market. The company was founded in 2008 and is headquartered in Yokneam, Israel, with additional offices and subsidiaries in the United States, China, Japan, and Europe.

Inmode's products are designed to address a wide range of aesthetic concerns, including skin aging, body contouring, hair removal, vascular lesions, and more. The company's flagship technology is the InMode Platform, an advanced radiofrequency-based platform that offers a wide range of treatment configurations and can be used for both surgical and non-surgical procedures.

The company has developed several innovative products that have been approved by regulatory bodies in various countries. These products include:

1. BodyTite - a minimally-invasive body contouring device that uses radiofrequency energy to melt fat and tighten skin.

2. FaceTite - a non-surgical facelift device that uses the same radiofrequency technology as BodyTite to lift and tighten sagging skin on the face and neck.

3. Morpheus8 - a microneedling device that combines radiofrequency energy with fractional technology to stimulate collagen production and improve skin texture and tone.

4. DiolazeXL - a diode laser hair removal device that offers fast, safe and effective treatment for all skin types and hair textures.

5. Votiva - a vaginal rejuvenation device that uses radiofrequency energy to improve sexual function and restore vaginal tissue.

Inmode's products have gained popularity among cosmetic surgeons and dermatologists due to their innovative technology, effectiveness, and safety. The company's business strategy is built on a direct sales model, and it has a strong global distribution network, with sales in over 100 countries worldwide.

In addition to its innovative products, Inmode is also known for its commitment to research and development. The company invests heavily in clinical research and has published numerous studies in peer-reviewed journals, providing scientific evidence to support the safety and effectiveness of its products.

Overall, Inmode Ltd is a leading player in the aesthetic device industry, continually developing innovative products that offer safe and effective solutions for patients around the world.

   Company Address: Tavor Building Yokneam 2069206
   Company Phone Number: 4-9096313   Stock Exchange / Ticker: NASDAQ INMD


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Inmode Ltd

Impressive Surge: INMDsn Unveils Robust Revenue Growth in Fourth Quarter of 2023

Inmode Ltd, a leading Medical Equipment & Supplies company, has demonstrated remarkable growth and success in its recent financial report. The company's revenue for the fiscal year ending December 31, 2023, increased by an impressive 8.316% to reach $492.05 million, compared to $454.27 million in the previous year.
One notable achievement for Inmode Ltd is its profits growth of 21.69%, with earnings per share rising to $2.30 from $1.89 in the prior year quarter. This indicates that the company has outperformed its contemporaries in the Medical Equipment & Supplies sector, which only showed a revenue growth of 4.26% during the same period.


Inmode Ltd's Segments
• View Complete Report
  Company Estimates  
  Revenue Outlook
Inmode Ltd does not provide revenue guidance.

Earnings Outlook
Inmode Ltd does not provide earnings estimates.

Geographic Revenue Dispersion


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com